Moderna and Merck's mRNA Vaccine Scores Big in Melanoma Trial

Yo, peep this! Moderna and Merck just scored big with their mRNA cancer vaccine, keepin' melanoma from comin' back for high-risk patients. In a Phase 3 trial with 1,137 players, this combo with Keytruda is lookin' real fresh, boostin' survival rates like never before. Ain't no new safety worries, just straight-up hope, baby!